Department of Psychiatry & Forensic Medicine, Institute of Neurosciences, Autonomous University of Barcelona, 08193-Bellaterra, Barcelona, Spain.
Curr Neuropharmacol. 2022;20(1):85-89. doi: 10.2174/1570159X19666211104144650.
The present perspective paper shortly and specifically addresses the issues of whether inhibition of GABA-A receptor-mediated synaptic transmission may be involved in antidepressantlike actions and the therapeutic effects of conventional antidepressant (AD) drugs, and whether the recent development of negative allosteric modulators (NAMs) of the alpha5-GABA-A receptor may constitute significant progress in our knowledge on the neurobiology and the treatment of depression.
本文简要而具体地探讨了 GABA-A 受体介导的突触传递抑制是否可能参与抗抑郁作用和传统抗抑郁药 (AD) 的治疗效果,以及最近开发的 α5-GABA-A 受体负变构调节剂 (NAM) 是否可能代表我们在抑郁症神经生物学和治疗方面的知识取得了重大进展。